Pancreatic disorders and diabetes mellitus

Experimental and Clinical Endocrinology and Diabetes

Volumn 116, Issue SUPPL. 1, 2008, Pages

  Melstradfeld, R ^a   Ehehalt, F ^a   Saegar, H D ^a   Solimena, Michele ^a,b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

Author keywords

Chronic pancreatitis; Diabetes mellitus; Pancreatic cancer

Indexed keywords

AMYLIN; CA 19-9 ANTIGEN; CALCIUM BINDING PROTEIN; CALGRANULIN A; GLUCOSE; INSULIN; METFORMIN;

ALCOHOL ABUSE; AUTOIMMUNE PANCREATITIS; CANCER RISK; CHRONIC PANCREATITIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; GENETIC ASSOCIATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERINSULINEMIA; INSULIN DEFICIENCY; INSULIN RESISTANCE; MORBIDITY; MORTALITY; NONHUMAN; ONCOGENE K RAS; PANCREAS CANCER; PANCREAS ISLET CELL CARCINOMA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; PANCREATIC DISEASES; PANCREATIC NEOPLASMS; RISK FACTORS;

EID: 54549100307     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1080918     Document Type: Review

References (75)

1. ADA. Type 2 diabetes in children and adolescents. American Diabetes Association. Diabetes Care 2000; 23 (3): 381-389
2. Bank S. Chronic pancreatitis: clinical features and medical management. Am J Gastroenterol 1986; 81 (3): 153-167
3. Basso D, Greco E, Fogar P, Pucci P, Flagiello A, Baldo G, Giunco S, Valerio A, Navaglia F, Zambon CF, Falda A, Pedrazzoli S, Plebani M. Pancreatic cancer-derived S-10OA8 N-terminal peptide: a diabetes cause? Clin Chim Acta 2006; 372 (1-2): 120-128
4. Basso D, Greco E, Fogar P, Pucci P, Flagiello A, Baldo G, Giunco S, Valerio A, Navaglia F, Zambon CF, Pedrazzoli S, Plebani M. Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications. Clin Chim Acta 2005; 357 (2): 184-189
5. Basso D, Valerio A, Seraglia R, Mazza S, Piva MG, Greco E, Fogar P, Gallo N, Pedrazzoli S, Tiengo A, Plebani M. Putative pancreatic cancer-associated diabetogenic factor: 2030 MW peptide. Pancreas 2002; 24 (1): 8-14
6. Bonelli L, Aste H, Bovo P, Cavallini G, Felder M, Gusmaroli R, Morandini E, Ravelli P, Briglia R, Lombardo L, Michell A De, Pugliese V. Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: A case-control study in Northern Italy. Pancreas 2003; 27 (2): 143-149
7. Bowker SL, Majumdar SR, Veugelers P, Johnson JA. Increased cancer-related mortality for patients with type 2 diabetes who use sulfanylureas or insulin. Diabetes Care 2006; 29 (2): 254-258
8. Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, Brentnall TA, Lynch HT, Canto MI. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 2007; 56 (10): 1460-1469
9. Bright R. Cases and observations connected with disease of the pancreas and duodenum. Med Chir Trans 1833; 18: 1-56
10. Bruns C, Diebold J, Heinemann V, Wilkowski R, Wagner A, Schmid R. Karzinome des exokrinen Panreas und der periampullären Region. In: Sendler, A. (ed). Manual Gastrointestinale Tumoren - Empfehlungen zur Diagnostik, Therapie und Nachsorge. München: Zuckschwerdt Verlage 2006; 77-99
11. Büchler MW, Friess H, Müller MW, Wheatley AM, Beger HG. Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis. Am J Surg 1995; 169 (1): 65-69: discussion 69-70
12. Chari ST, Klee GG, Miller LJ, Raimondo M, Magno EP Di. Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer. Gastroenterology 2001; 121 (3): 640-645
13. Chari ST, Leibson CL, Rabe KG, Ransom J, Andrade M de, Petersen GM. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 2005; 129 (2): 504-511
14. Chari ST, Leibson CL, Rabe KG, Timmons LJ, Ransom J, Andrade M de, Petersen GM. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 2008; 134 (1): 95-101
15. Czyzyk A, Szczepanik Z. Diabetes mellitus and cancer. Eur J Intern Med 2000; 11 (5): 245-252
16. Damiano J, Bordier L, Le Berre JP, Mrgery J, Dupuy O, Mayaudon H, Bauduceau B. Should pancreas imaging be recommanded in patients over 50 years when diabetes is discovered because of acute symptoms? Diabetes Metab 2004; 30 (2): 203-207
17. Davalli AM, Pontiroli AE, Bertuzzi F, Pozza G, Socci C, Carlo V Di, Freschi M. In vitro function of human islets isolated from the pancreas of a cadaveric donor with diabetes mellitus secondary to chronic pancreatitis. Pancreas 1994; 9 (1): 134-136
18. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 1995; 273 (20): 1605-1609
19. Fisher WE, Boros LG, Schirmer WJ. Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors. J Surg Res 1996; 63 (1): 310-313
20. Fisher WE, Muscarella P, Boras LG, Schirmer WJ. Variable effect of streptozotocin-diabetes on the growth of hamster pancreatic cancer (H2T) in the Syrian hamster and nude mouse. Surgery 1998; 123 (3): 315-320
21. Fogar P, Basso D, Pasquali C, Piva MG, Brigato L, Paoli M De, Galeotti F, Corsini A, Plebani M. Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer. Clin Chim Acta 1998; 277 (2): 181-189
22. Fogar P, Pasquali C, Basso D, Sperti C, Panozzo MP, Tessari G, DAngeli F, Del Favero G, Plebani M. Diabetes mellitus in pancreatic cancer follow-up. Anticancer Res 1994; 14 (6B): 2827-2830
23. Friedman GD, Eeden SK van den. Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol 1993; 22 (1): 30-37
24. Frye JN, Inder WJ, Dobbs BR, Frizelle FA. Pancreatic cancer and diabetes: is there a relationship? A case-controlled study. Aust N Z J Surg 2000; 70 (10): 722-724
25. Fryzek JP, Garabrant DH, Schenk M, Kinnard M, Greenson JK, Sarkar FH. The association between selected risk factors for pancreatic cancer and the expression of p53 and K-ras codon 12 mutations. Int J Gastrointest Cancer 2006; 37 (4): 139-145
26. Gavin JR, Alberti KGMM, Davidson MB, DeFronzo RA, Drash A, Gabbe SG, Genuth S, Harris MI, Kahn R, Keen H, Knowler WC, Lebovitz H, Maclaren NK, Palmer JP, Raskin P, Rizza RA, Stern MP. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; S5-20
27. Goto M, Nakano I, Kimura T, Miyahara T, Kinjo M, Nawata H. New chronic pancreatitis model with diabetes induced by cerulein plus stress in rats. Dig Dis Sci 1995; 40 (11): 2356-2363
28. Gullo L. Diabetes and the risk of pancreatic cancer. Ann Oncol 1999; 10 (Suppl 4): 79-81
29. Gullo L, Pezzilli R, Morselli-Labate AM. Diabetes and the risk of pancreatic cancer. Italian Pancreatic Cancer Study Group. N Engl J Med 1994; 331 (2): 81-84
30. Gupta S, Vittinghoff E, Bertenthal D, Corley D, Shen H, Walter LC, Mac-Quaid K. New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol 2006; 4 (11): 1366-1372; quiz 1301.
31. Gupta V, Toskes PP. Diagnosis and management of chronic pancreatitis. Postgrad Med J 2005; 81 (958): 491-497
32. Hedetoft C, Sheikh SP, Larsen S, Holstt JJ. Effect of glucagon-like peptide 1(7-36) amide in insulin-treated patients with diabetes mellitus secondary to chronic pancreatitis. Pancreas 2000; 20 (1): 25-31
33. Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A. Cancer and diabetes - a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 1997; 241 (6): 471-475
34. Hull RL, Westermark GT, Westermark P, Kahn SE. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 2004; 89 (8): 3629-3643
35. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005; 92 (11): 2076-2083
36. Isaksson B, Strommer L, Friess H, Buchler MW, Herrington MK, Wang F, Zierath JR, Wallberg-Henriksson H, Larsson J, Permert J. Impaired insulin action on phosphatidylinositol 3-kinase activity and glucose transport in skeletal muscle of pancreatic cancer patients. Pancreas 2003: 26 (2): 173-177
37. Ishikawa O, Ohhigashi H, Wada A, Tateishi R, Ishiguro S, Okano Y, Sasaki Y, Imaoka S, Koyama H, Iwanaga T. Morphologic characteristics of pancreatic carcinoma with diabetes mellitus. Cancer 1989; 64 (5): 1107-1112
38. Ishikawa O, Ohigashi H, Imaoka S, Nakai I, Mitsuo M, Weide L, Pour PM. The role of pancreatic islets in experimental pancreatic carcinogenicity. Am J Pathol 1995; 147 (5): 1456-1464
39. Ito T, Otsuki M, Itoi T, Shimosegawa T, Funakoshi A, Shiratori K, Naruse S, Kuroda Y. Pancreatic diabetes in a follow-up survey of chronic pancreatitis in Japan. J Gastroenterol 2007; 42 (4): 291-297
40. Klöppel G, Bommer G, Commandeur G, Heitz P. The endocrine pancreas in chronic pancreatitis. Immunocytochemical and ultrastructural studies. Virchows Arch A Pathol Anat Histol 1978; 377 (2): 157-174
41. Litwin J, Dobrowolski S, Orlowska-Kunikowska E, Sledzinski Z. Changes in glucose metabolism after Kausch-Whipple pancreatectomy in pancreatic cancer and chronic pancreatitis patients. Pancreas 2008; 36 (1): 26-30
42. Liu J, Kazakaff K, Pour PM, Adrian TE. The intracellular mechanism of insulin resistance in the hamster pancreatic ductal adenocarcinoma model. Pancreas 1998; 17 (4): 359-366
43. Liu J, Knezetic JA, Strommer L, Permert J, Larsson J, Adrian TE. The intracellular mechanism of insulin resistance in pancreatic cancer patients. J Clin Endocrinol Metab 2000; 85 (3): 1232-1238
44. Malka D, Hammel P, Sauvanet A, Rufat P, O'Toole D, Bardet P, Belghiti J, Bernades P, Ruszniewski P, Levy P. Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology 2000: 119 (5): 1324-1332
45. Michaud DS, Wolpin B, Giovannucci E, Liu S, Cochrane B, Manson JE, Pollak MN, Ma J, Fuchs CS. Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women. Cancer Epidemiol Biomarker Prev 2007; 16 (10): 2101-2109
46. Monami M, Lamanna C, Pala L, Bardini G, Cresci B, Francesconi P, Balzi D, Marchionni N, Rotella CM, Mannucci E. Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort study. Exp Clin Endocrinol Diabetes 2008; 116 (3): 184-189
47. Mossner J, Logsdon CD, Williams JA, Goldfine ID. Insulin, via its own receptor, regulates growth and amylase synthesis in pancreatic acinar AR42J cells. Diabetes 1985; 34 (9): 891-897
48. Nyboe Andersen B, Krarup T, Thorsguard Pedersen NT, Faber OK, Hagen C, Worning H. B cell function in patients with chronic pancreatitis and its relation to exocrine pancreatic function. Diabetologia 1982; 23 (2): 86-89
49. Oosterwijk C, Hulst KL van, Visser CJ, Woutersen RA, Lips CJ, Tweel JG van den, Hoppener JW. Pancreatic cancer in rats and hamsters does not induce IAPP-related hyperglycaemia. Int J Cancer 1997: 72 (4): 637-641
50. Opie E. On the relation of chronic interstitial pancreatitis to the islands of Langerhans and to diabetes mellitus. J exp Med 1901: 5 (4): 397-428
51. Pelaez-Luna M, Takahashi N, Fletcher JG, Chari ST. Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis. Am J Gastroenterol 2007: 102 (10): 2157-2163
52. Permert J, Adrian TE, Jacobsson P, Jorfelt L, Fruin AB, Larsson J. Is pro-found peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg 1993a; 165 (1): 61-66; discussion 66-67
53. Permert J, Ihse I, Jorfeldt L, Schenck H von, Arnqvist HJ, Larsson J. Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 1993b; 159 (2): 101-107
54. Permert J, Larsson J, Fruin AB, Tatemoto K, Herrington MK, Schenck H von, Adrian TE. Islet hormone secretion in pancreatic cancer patients with diabetes. Pancreas 1997; 15 (1): 60-68
55. Permert J, Larsson J, Westermark GT, Herrington MK, Christmanson L, Pour PM, Westermark P, Adrian TE. Islet amyioid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med 1994: 330 (5): 313-318
56. Permert J, Mogaki M, Andren-Sandberg A, Kazukoff K, Pour PM. Pancreatic mixed ductal-islet tumors. Is this an entity? Int J Pancreatol 1992; 11 (1): 23-29
57. Perrin MC, Terry AM, Kleinhaus K, Deutsch L, Yanetz R, Tiram E, Calderon R, Friedlander Y, Paltiel O, Harlap S. Gestational diabetes as a risk factor for pancreatic cancer: a prospective cohort study. BMC Med 2007; 5: 25
58. Pour PM, Duckworth W, Carlson K, Kazakoff K. Insulin therapy prevents spontaneous recovery from streptozotocin-induced diabetes in Syrian hamsters. An autoradiographic and immunohistochemical study. Virchows Arch A Pathol Anat Histopathol 1990; 417 (4): 333-341
59. Pour PM, Stepan K. Modification of pancreatic carcinogenesis in the hamster model. VIII. Inhibitory effect of exogenous insulin. J Natl Cancer Inst 1984; 72 (5): 1205-1208
60. Pour PM, Weide L, Liu G, Kazakoff K, Scheetz M, Toshkov I, Ikematsu Y, Fienhold MA, Sanger W. Experimental evidence for the origin of ductal-type adenocarcinoma from the islets of Langerhans. Am J Pathol 1997; 150 (6): 2167-2180
61. Ragozzino M, Melton 3rd LJ, Chu CP, Palumbo PJ. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 1982; 35 (1): 13-19
62. Schneider MB, Matsuzaki H, Hoorah J, Ulrich A, Standop J, Ding XZ, Adrian TE, Pour PM. Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology 2001: 120 (5): 1263-1270
63. Silverman DT, Swanson CA, Gridley G, Wacholder S, Greenberg RS, Brown LM, Hayes RB, Swanson GM, Schoenberg JB, Pattern LM, Schwartz AG, Fraumeni Jr JF, Hoover RN. Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst 1998; 90 (22): 1710-1719
64. Slebos RJC, Hoppin JA, Tolbert PE, Holly EA, Brock JW, Zhang RH, Bracci PM, Foley J, Stockton P, MacGregor LM, Flake GP, Taylor JA. K-ras and p53 in pancreatic cancer: Association with Medical History, Histopathology, and Environmental Exposures in a Population-based Study. Cancer Epidemiol Biomarkers Prev 2000; 9 (11): 1223-1232
65. Steer ML, Waxman I, Freedman S. Chronic pancreatitis. N Engl J Med 1995; 332 (22): 1482-1490
66. Stevens RJ, Roddam AW, Beral V. Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis. Br J Cancer 2007; 96 (3): 507-509
67. Tateishi K, Magno EP Di, Klee GG. Plasma islet amyloid polypeptide is not an effective tumor marker for pancreatic cancer even when protease inhibitors and rapid freezing of specimens are utilized. Clin Chem 2001; 47 (11): 2071-2073
68. Uygur-Bayramicli O, Dabak R, Orbay E, Dolapcioglu C, Sargin M, Kilicoglu G, Guleryuzlu Y, Mayadagli A. Type 2 diabetes mellitus and CA 19-9 levels. World J Gastroenterol 2007; 13 (40): 5357-5359
69. Wakasugi H, Funakoshi A, Iguchi H. Clinical observations of pancreatic diabetes caused by pancreatic carcinoma, and survival period. Int J Clin Oncol 2001; 6 (1): 50-54
70. Wang F, Gupta S, Holly EA. Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Cancer Epidemiol Biomarkers Prev 2006; 15 (8): 1458-1463
71. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 1987; 84 (11): 3881-3885
72. WHO. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Geneva 1999
73. Woods SC, Lutz TA, Geary N, Langhans W. Pancreatic signals controlling food intake; insulin, glucagon and amylin. Philos Trans R Soc Land B Biol Sci 2006; 361 (1471): 1219-1235
74. Zendehdel K, Nyren O, Ostenson CG, Adami HO, Ekbom A, Ye W. Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst 2003; 95 (23): 1797-1800
75. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414 (6865): 782-787